The process of selecting a contract development and manufacturing organisation (CDMO) can be a turning point in pharmaceutical development.
The right CDMO can make the difference when it comes to strengthening manufacturing capabilities, ensuring regulatory compliance and facilitating the timely delivery of products to market.
To successfully navigate this process, companies must consider a range of essential criteria when choosing potential CDMO partners, ensuring alignment with both operational and strategic objectives. Below are the key factors to guide the decision-making process.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.